A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

Clinical trial NCT03058289 · COMPLETED

Trial details

NCT number: NCT03058289
Sponsor: Intensity Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Head and Neck Cancer Squamous Cell Carcinoma Lymphoma Pancreatic Cancer Liver Cancer Colon Cancer Lung Cancer Bile Duct Cancer Chordoma of Sacrum Sarcoma

Start date: 2017-02-09
Primary completion: 2023-02-22
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.